Kiromic BioPharma Inc. (KRBP)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.87
-0.13 (-13.00%)
At close: Jan 17, 2025, 3:20 PM
0.00
-100.00%
After-hours Dec 31, 1969, 07:00 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
PE Ratio | -0.04 | -0.08 | -0.68 | -3.21 | -11.9 | -10.65 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | -0.1 | -0.51 | 0.64 | 5.43 | 22.54 | 153.14 |
P/FCF Ratio | -0.04 | -0.1 | -0.79 | -8.14 | -13.87 | -17.74 |
P/OCF Ratio | -0.04 | -0.12 | -0.86 | -10.07 | -15.31 | -18.87 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | -1.7 | -1.63 | 0.02 | 0.04 | n/a | n/a |
Quick Ratio | 0.22 | 0.13 | 7.94 | 7.32 | 3.00 | 0.89 |
Current Ratio | 0.22 | 0.13 | 7.94 | 7.32 | 3.03 | 0.92 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | 10.77 | -186.87 | -2.11K | -5.82K | -164.68 | -5.03 |
Return on Equity (ROE) | 2.33 | 6.61 | -0.94 | -1.69 | -1.9 | -14.38 |
Return on Assets (ROA) | -1.75 | -3.19 | -0.83 | -1.5 | -1.41 | -4.36 |
Return on Capital (ROIC) | 2.43 | 23.65 | -0.94 | -1.69 | -1.87 | -12 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |